Effects of Continuous Plasma-Derived Subcutaneous C1-Esterase Inhibitor on Coagulation and Fibrinolytic Parameters

Thromb Haemost. 2021 May;121(5):690-693. doi: 10.1055/s-0040-1721147. Epub 2020 Nov 17.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Angioedemas, Hereditary / blood
  • Angioedemas, Hereditary / prevention & control*
  • Blood Coagulation / drug effects*
  • Complement C1 Inhibitor Protein / administration & dosage
  • Complement C1 Inhibitor Protein / therapeutic use*
  • Female
  • Fibrin Fibrinogen Degradation Products / analysis
  • Fibrinolysis / drug effects
  • Humans
  • Male
  • Middle Aged
  • Placebo Effect

Substances

  • Complement C1 Inhibitor Protein
  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D